activity
20212026
most citedLearning From Drift: Federated Learning on Non-IID Data via Drift Regularization

2 citations · 6 across the 12 of their papers we have counts for

collaborators
Showing cs.LGShow all

6 papers · 1 filter

cs.LG2025

Bridging the Gap Between Molecule and Textual Descriptions via Substructure-aware Alignment

Hyuntae Park, Yeachan Kim, SangKeun Lee

Molecule and text representation learning has gained increasing interest due to its potential for enhancing the understanding of chemical information. However, existing models ofte…

cs.LG2024

C2A: Client-Customized Adaptation for Parameter-Efficient Federated Learning

Yeachan Kim, Junho Kim, Wing-Lam Mok +2

Despite the versatility of pre-trained language models (PLMs) across domains, their large memory footprints pose significant challenges in federated learning (FL), where the traini…

cs.LG2024

CleaR: Towards Robust and Generalized Parameter-Efficient Fine-Tuning for Noisy Label Learning

Yeachan Kim, Junho Kim, SangKeun Lee

Parameter-efficient fine-tuning (PEFT) has enabled the efficient optimization of cumbersome language models in real-world settings. However, as datasets in such environments often…

cs.LG2023★ 2 cited

Learning From Drift: Federated Learning on Non-IID Data via Drift Regularization

Yeachan Kim, Bonggun Shin

Federated learning algorithms perform reasonably well on independent and identically distributed (IID) data. They, on the other hand, suffer greatly from heterogeneous environments…

cs.LG2023

Phase-shifted Adversarial Training

Yeachan Kim, Seongyeon Kim, Ihyeok Seo +1

Adversarial training has been considered an imperative component for safely deploying neural network-based applications to the real world. To achieve stronger robustness, existing…

cs.LG2021★ 2 cited

An Interpretable Framework for Drug-Target Interaction with Gated Cross Attention

Yeachan Kim, Bonggun Shin

In silico prediction of drug-target interactions (DTI) is significant for drug discovery because it can largely reduce timelines and costs in the drug development process. Specific…